Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>Mutations of the cyclin‐dependent kinase‐like 5 (<i>CDKL5</i>) gene cause severe neurodevelopmental disorders characterized by intractable epilepsy, intellectual disability, and autism. Multiple mouse models generated for mechanistic studies have exhibited phenotypes similar to some human pathological features, but none of the models has developed one of the major symptoms affecting CDKL5 deficiency disorder (CDD) patients: intractable recurrent seizures. As disrupted neuronal excitation/inhibition balance is closely associated with the activity of glutamatergic and γ‐aminobutyric acidergic (GABAergic) neurons, our aim was to study the effect of the loss of CDKL5 in different types of neurons on epilepsy. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Using the Cre‐LoxP system, we generated conditional knockout (cKO) mouse lines allowing CDKL5 deficiency in glutamatergic or GABAergic neurons. We employed noninvasive video recording and in vivo electrophysiological approaches to study seizure activity in these <i>Cdkl5</i> cKO mice. Furthermore, we conducted Timm staining to confirm a morphological alteration, mossy fiber sprouting, which occurs with limbic epilepsy in both human and mouse brains. Finally, we performed whole‐cell patch clamp in dentate granule cells to investigate cell‐intrinsic properties and synaptic excitatory activity. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>We demonstrate that Emx1‐ or CamK2α‐derived <i>Cdkl5</i> cKO mice manifest high‐frequency spontaneous seizure activities recapitulating the epilepsy of CDD patients, which ultimately led to sudden death in mice. However, <i>Cdkl5</i> deficiency in GABAergic neurons does not generate such seizures. The seizures were accompanied by typical epileptic features including higher amplitude spikes for epileptiform discharges and abnormal hippocampal mossy fiber sprouting. We also found an increase in spontaneous and miniature excitatory postsynaptic current frequencies but no change in amplitudes in the dentate granule cells of Emx1‐cKO mice, indicating enhanced excitatory synaptic activity. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Significance</h3><p>Our study demonstrates that <i>Cdkl5</i> cKO mice, serving as an animal model to study recurrent spontaneous seizures, have potential value for the pathological study of CDD‐related seizures and for therapeutic innovation. </p></section>

Altered network and rescue of human neurons derived from individuals with early-onset genetic epilepsy

Neuronal hyperexcitability and ion channel dysfunction in CDKL5-deficiency patient iPSC-derived cortical organoids

Novel CDKL5 targets identified in human iPSC-derived neurons

Excitatory Cortical Neurons from CDKL5 Deficiency Disorder Patient-Derived Organoids Show Early Hyperexcitability Not Identified in Neurogenin2 Induced Neurons

Modeling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient-derived induced pluripotent stem cells

CDKL5 deficiency in forebrain glutamatergic neurons results in recurrent spontaneous seizures

Altered synaptic connectivity in an in vitro human model of STXBP1 encephalopathy

Altered development and network connectivity in a human neuronal model of 15q11.2 deletion-related neurodevelopmental disorders

Plural molecular and cellular mechanisms of pore domain KCNQ2 encephalopathy

Abnormal synaptic architecture in iPSC-derived neurons from a multi-generational family with genetic Creutzfeldt-Jakob disease

Enhanced hippocampal LTP but normal NMDA receptor and AMPA receptor function in a rat model of CDKL5 deficiency disorder

Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder

Rescue of neuropsychiatric phenotypes in a mouse model of 16p11.2 duplication syndrome by genetic correction of an epilepsy network hub

Multimodal single-cell profiling reveals neuronal vulnerability and pathological cell states in focal cortical dysplasia

Dissecting the Role of PCDH19 in Clustering Epilepsy by Exploiting Patient-Specific Models of Neurogenesis

Modeling Cortical Versus Hippocampal Network Dysfunction in a Human Brain Assembloid Model of Epilepsy and Intellectual Disability

Loss of symmetric cell division of apical neural progenitors drives -related developmental and epileptic encephalopathy

Generation of a human induced pluripotent stem cell (iPSC) line from a patient with a CDKL5 gene mutation

Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology

Neuronal Defects in a Human Cellular Model of 22q11.2 Deletion Syndrome.

Antisense oligonucleotide therapy for KCNT1 encephalopathy